**Core Concept**
The question is testing the neuropathologic changes associated with Down syndrome, particularly in the context of acute lymphoblastic leukemia. Down syndrome is a genetic disorder characterized by an extra copy of chromosome 21, leading to various physical and developmental abnormalities, including cognitive impairment and increased risk of leukemia.

**Why the Correct Answer is Right**
In individuals with Down syndrome, there is a higher incidence of Alzheimer's disease-like neuropathology, including amyloid-beta plaques and neurofibrillary tangles. The underdevelopment of the superior temporal gyri, as observed in this patient, is consistent with the neuropathologic changes associated with Down syndrome. The presence of amyloid-beta plaques and neurofibrillary tangles would be indicative of Alzheimer's disease-like pathology.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not specific to Down syndrome or Alzheimer's disease-like pathology. While it is a common neuropathologic finding, it is not the most likely change in this context.
**Option B:** This option is also not specific to Down syndrome or Alzheimer's disease-like pathology. It is a general term that could refer to various neuropathologic changes, but it is not the most accurate description of the changes associated with Down syndrome.
**Option C:** This option is not a neuropathologic change associated with Down syndrome or Alzheimer's disease-like pathology. It is a general term that could refer to various conditions, but it is not relevant to the context of this question.

**Clinical Pearl / High-Yield Fact**
Individuals with Down syndrome are at increased risk of developing Alzheimer's disease-like neuropathology, including amyloid-beta plaques and neurofibrillary tangles. This is an important consideration in the management and care of patients with Down syndrome, particularly as they age.

**Correct Answer:** C.